The variety of factors controlling the onset of parturition, äs well äs the very complex mechanisms which physiologically maintain pregnancy by inhibiting uterine contractions are only partially understood today. As long äs the triggering mechanisms, and the conditions favoring timely and early labor are incompletely known, symptomatic therapeutic attempts aim at blocking unwanted contractile activity of the uterine smooth muscle fibres. The high rates of neonatal mortality and morbidity associated with premature births [52] have stimulated efforts to find agents which safely inhibit uterine contractions in humans.
sure in vivo have been demonstrated recently [35] . In Tab. I some clinical results in the treatment of premature labor are summarized. In spite of the wide application of adrenergic jß-mimetic agents to inhibit premature labor, the fetakieonatal effects of the compounds used have been rather poorly evaluated in the past.
The complex of the ß-stimulated res-
ponse An approach to the evaluation of the possible influences of tocolytic catecholamine derivatives on the fetus has to Start from the fact that the relaxation of uterine smooth muscle is only one component of the ß-stimulated response. The spectrum of effects triggered off by the /?-adrenergic Stimulus additionally consists of cardio vascular and metabolic reactions [24] . [44] [9, 66] [62] [71] A) Catdiovascular reactions: 1. Positive chronotropic and positive inotropic Stimulation of the myocardium cause tachycardia. 2. Vasodilatation increases the peripheral bloodflow. 3 . Systolic and diastolic hypotonia.
B) Metabolie reactions:
Stimulation of the cell membrane enzyme adenyl cyclase, which cätalyzes the intracellular formation of cyclic 3'5'-adenosine monophosphate from adenosine triphosphate. Cyclic 3'5'-AMP catalyzes the activation of: 1. Glycogen phosphorylase 2. Lipase.
Glycogenolysis and lipolysis are estbalished ß-mimetic effects, and result in marked changes in intra-and extracellular concentrations of carbohydrate-and fat metabolites.
The evaluation of possible fetal-neonatal influences of tocolytic catecholamine derivatives has to take into consideration the whole pattern of ß-stimulated responses.
Influence upon the fetus, and possibilities
of evaluating these effects The fetal organism may be involved in two ways, which may act in conjunction: A) 1. Maternal cardiovascular reactions to /?-mimetic drugs influence the utero-placental and fetal circulation. 2. According to the level of maternal concentrations, carbohydrate-and fat metabolites are increasingly transferred accross the placenta causing alterations of the fetal metabolic homeostasis.
B) The tocolytic substances are readily transferred across the placenta and induce the complete typical pattern of ß-stimulated responses in the fetal organism itself. In contrast to the mother, the fetus is generally not accessible for assays of metabolism. Successful administration of *-tocolytics with Inhibition of premature labor and advancement of parturition almost exclude availability of the fetus and newborn to direct investigations of biochemical Parameters. Studies of the fetal Situation during tocolytic therapy are therefore mainly restricted J. Perinat. Mcd. 2 (1974) to the observation of fetal-heart-rate-patterns. The methods used are fetal phono-or electrocardiography and the ultrasonic Doppler-signal. Other useful parameters are in some cases amnioscopy, and during long-time application continous measurement of oestriol-and human placental lactogen concentrations, together with ultrasound cephalometry. Some investigators have admin istered tocolytics during an advanced stage of parturition and collected micro-blood-specimens from the presenting part for blood-gas-analysis. In other cases newborns were examined following failure of tocolytic therapy.
Cardiovascular effects
In the concentrations essential for tocolytic efficiency all the adrenergic ß-mimetic compounds affect the cardiovascular System, occasionally to a significant degree, thus limiting their clinical usefulness. The maternal hypotensive and cardioaccelatory efFects associated with the use of /?-mimetic tocolytics have been emphasized by many authors [4, 5, 6, 7, 8, 11, 12, 16, 28, 29, 31, 36, 39, 43, 45, 46, 49, 54, 57, 58, 63, 66, 67, 68, 69, 72] , Additional administration of Iproveratril has proved to be efficient in reducing the maternal cardiovascular side effects. Moreover this compound may act synergistically with the /?-mimetics in inhibiting uterine activity [42, 43, 49, 52 , 64],
Influence upon fetal circulation
The influence of ß-mimetic catecholamines upon the fetal circulation has been reviewed by ESKES and DE HAAN recently [21] . Usually the fetal heart rate increases during infusion of ß-mimetics [10, 21, 29, 31, 45, 57, 62, 67] . During infusion of 0.05-0.2mg Ritodrine/min, however, some authors found no significant acceler ation of the fetal heart rate [5, 8, 66] , even when maternal tachycardia was significant [36] , Also with Ritodrine concentrations äs high äs 0.38 mg/min the fetal heart rate remained within the limits of normal values, while a moderate acceleration in maternal heart rate from 70 to 105 beats/min was significant [11] . With Orciprenaline (0.02-0.04 mg/min i. v.) a moderate increase of the fetal heart rate appeared 30 min after start of infusion [72] . When 0.1-0.6mg/ min Du 21220 were given intravenously during parturition, the increase of maternal heart rate was dose-dependent. The fetal heart rate acceleration, however, did not display this relationship [25] . With 1.5-3.0^g/min Th 1165 a i. v. a fetal tachycardia of +3% was observed, which in contrast to the mother started later and reached a maximum of +5% when the infusion had already ended [29] . According to these results, fetal heart rate acceleration during administration of ß-mimetic tocolytics is independent of maternal tachycardia. The fetal tachycardia presumably indicates that tocolytic agents, having crossed the placenta, directly stimulate the ß-receptors in the fetal myocardium [31, 57, 72] . ESKES and DE HAAN [21] studied six aspects of fetal heart rate by a method of Computer evaluation. The /?-mimetic catecholamines did not influence the patterns of short-time irregularity, except when the basal heart frequency increased to over 150 beats/min. No changes of the fetal electrocardiogram were observed by several authors using Isoxsuprine [6, 56, 57] .
Infusion of /?-mimetric in lateral position
Maternal cardiovascular reaction to tocolytic jS-mimetic drugs, however, can have a profound influence on the fetal circulation, when severe maternal hypotension occurs [21] . During infusion of /?-mimetics in the supine position, a breakdown of the uteroplacental bloodflow with its detrimental effects on the fetus results from a supine hypotensive syndrome [19, 29, 57] . CRAWFORD [15] noted that frequently a decreased venous return is compensated for a time by vasoconstriction. In those cases ß-stimulated peripheral vasodilatation may antagonize this endogenous compensation, endangering the uteroplacental blood-flow. Therefore a lateral position during infusion of /5-mimetic tocolytics is generally recommended.
Failure of the placental respiratory function
On the other hand, /?-stimulated peripheral vasodilatation together with a wider pulse amplitude, resulting from unchanged systolic blood pressure when the diastolic tension is lowered [69] , and an increased maternal cardiac Output consequently enhance placental perfusion, improving the oxygen supply to the fetus. This is especially the case when this effect is additional to the desired relaxation of the Uterus. When chronic placental insufficiency exists, normal labor contractions and especially hyperactive contractions are likely to produce an acute failure of the placental respiratory function. Diminution of frequency and intensity of uterine contractions, äs well äs reduction of the uterine basal tonus by tocolytics interfere with the pathophysiological mechanisms of acute placental insufficiency [50] . GAMISSANS, ESTEBAN-ALTIR-RIBA and MAIQUES [25] In most of their patients they were able to achieve a significant rise of former acidotic or preacidotic fetal capillary pH values together with the Inhibition of labor contractions. Fetal Pco 2 decreased in cases of respiratory and mixed acidosis, and tended to increase when metabolic acidosis prevailed [26] . According to their results with a group of another 41 cases of suspected intra partum fetal acidosis due to uterine hyperactivity or cord compression, they now recommend a 15 minute-treatment trial with tocolytic infusion, before the fetus is delivered [22] . KÜNZEL and REINECKE during 20 min infusion of 0.03 Th 1165 a/min/kg body weight intra partum found an increase of fetal capillary blood Po 2 from 15.6 to 18.2 mm Hg. Fetal oxygen Saturation was elevated from 31.5 to 38.4%, pH and Pco 2 remained unchanged., These results, corresponding to an increase of fetal capillary blood oxygen concentration of 1.5 ml/100 ml were supposed to be due to better uterine perfusion during /?-mimetic relaxation of the uterus [35] .
/?-mimetics in EPH-gestosis
VAHRSON and SCHWARZ [63] reported 12 cases of severe EPH-gestosis where a reduction of systolic and diastolic hypertension was brought about by intravenous infusion of Buphenin without impairing the oxygen supply to the fetus. Normalization of hypertension, increased uteroplacental blood-flow by peripheral vasodilatation with improved intrauterine conditions for the dysmature and placentalinsufficiency-endangered fetus are the basis for therapeutic long-time trials in EPH-gestosis [42] . This mode of action may also explain some authors' observations of increased biparietal diameters and higher birth-weights following long-time administration of ß-mimetics [29, 49, 52] .
Effects upon carbohydrate and fat
metabolism Another Interpretation of possibly increased fetal growth during tocolytic long-time therapy may be given by continuously elevated maternal blood glucose levels, resulting from jö-mimetic effects upon carbohydrate metabolism. Contrast to the well known and thoroughly studied maternal cardiovascular alterations caused by ß-mimetic tocolytics, the metabolic effects of the compounds used have not been sufficiently noticed until recently. JUNG, ABRAMOWSKI, KLÖCK and SCHWENZEL [31] reported an immediate severe increase of blood glucose concentrations, together with glycosuria and ketonuria in a pregnant diabetic during tocolytic jtreatment. LIPPERT, KUBLI and RÜTT-GERS [38] demonstrated the hyperglycemic activity of Isoxsuprine and Buphenin in pregnant women. 60 minutes after the intramuscular injection of 5 mg Buphenin the blood glucose concentration had risen to 150% of the starting level. 10 mg Isoxsuprine, however, caused only a non-significant increase of 8.6%. They also found marked hyperglycemia, glycosuria and aceton-uria following administration of Isoxsuprine or Buphenin to diabetic pregnant women.
More detailed examinations of ß-mimetic efFects upon carbohydrate and fat metabolism during tocolytic therapy have been reported lately by some groups of investigators. During oral, intramuscular or intravenous application of Dilatol or Th 1165 a maternal blood glucose levels increased 10-40% above the starting level; when Dilatol is infused intravenously, maternal glucose concentration doubled immediately [55] , (average 90 ^g) Dylidrin/min i. v. caused an increase of maternal glucose from 82 to 140 mg/100 ml [51] . At the time, 1/jg Th 1165 a/min is infused for 24-48 hrs, and daily variations in blood glucose concentrations are likewise elevated [37] .
After 5mg Th 1165 had been given orally, pregnant women without uterine contractions reacted with an average increase of 40 mg/100 ml in blood glucose within 90 min. Another 90 min later, glucose levels had normalized [64] , Pathologie high blood glucose concentrations were found following an oral glucose load of 50 g during Dilatol-or Th 1165 a therapy [55] . Glucose assimilation has been found unchanged by some [64] , others, however, have reported an impairment of glucose assimilation following a combined insulin-glucose-tolerance test during tocolytic therapy [37] , After oral administration of 5 mg Th 1165 a maternal insulin concentrations were found increased, following the rise of glucose concentrations with a short time-lag [64] . During long-time application other authors determined rather low levels of maternal insulin concentrations [37] . When 3^g Th 1165 a/min were infused intravenously for 4 hours in a homogeneous group of normal healthy pregnant women at term, not in labor and having fasted for 8 hours, blood glucose concentrations showed a continous rise which became significant after 60 min. A the same time the insulin concentrations were 5 times higher than the starting levels and decreased slightly in the following 3 hours. Free fatty acids and free glycerol concentrations doubled, lactate and pyruvate concentrations rose continously, reaching levels 3 times higher than at the Start of the infusion. Acetoacetate and /J-hydroxybutyrate concentrations rose immediately when the ß-mimetic was infused. Having reached a 2-2.5 fold increase, beginning from the second hour, acetoacetate and ß-hydroxybutyrate declined slowly, free fatty acids and free glycerol acted in the same way, while the concentrations of neutral fats, total glycerol and esterified glycerol were changed at first, showing an increase from the second hour until the end of the infusion. Within 60 min after the end of the infusion, nearly all the changes of metabolite concentrations had normalized with the exception of the pyruvate and lactate levels [14, 61, 62] .
15min after starting an infusion of 0.12mg TV 399/min in pregnancies at term without uterine contractions, maternal lactate concentrations increased from 11.51 to 24.94 mg/100 ml, the pyruvate concentrations rose from 0.256 to 0.392 mg/100 ml. Maternal actual pH values appeared to be rather on the acid side [45] , Also WOLFF [70] reported a decrease in maternal base excess and actual pH, still within normal ranges, 15 min after the end of a 60 min infusion of 0.17 mg Dilatol/min. During infusion of 2/jg Th 1165 a/min at the beginning of the first stage of labor, maternal actual pH, äs well äs base excess decreased significantly, Po 2 and Pco 2 underwent no significant changes [33] . When 0.1 mg Buphenin/min is used under similar conditions, maternal acidbase parameters remain unchanged [33, 51] .
Potassium concentration during infusion of /?-mimetics
Another response typical for ß-mimetic compounds is a decrease in plasma potassium concentrations, resulting from a shift in the intracellular -extracellular potassium balance [23, 40] . During infusion of 3^g Th 1165 a/min a highly significant rapid fall of potassium concentrations in maternal serum was found, reaching levels äs low äs 2.8 mval/1. 60 min after the end of the infusion the potassium concentrations had recovered [61, 62] .
Changes in maternal metabolism
hydroxybutyrate readily pass across the placenta into the fetal organism. Maternal high concenSummarizing these corresponding results, it can tration § of acid meta bolites are most likely to be concluded that immediately after startmg a duce ft feftd metabolic acido sis. In contrast tocolytic therapy by an infusion of 0-mimettc ^ ^ ^ low . mokcular acids> free fatty agents lipolysis and glycogenolysis are tng-^.^ ^ bouiid tQ albumin and cannot gered off. The glycogen reserves are mobilized. ^^ ^ p i acenta [74] , High lactate levels are mainly evidence of hydrolysis of muscle glycogen. Acute lipolytic mobi-g e Placental transfer and metabolism of lizing of fat reserves causes increases of free fatty catecholamines acids, the high concentrations of which evidently Catecholamines do cross the placental memblock the metabolizing of acetyl-co-A, thus branes ^ humanSe When i4 C _i abe lled norepineleading to excessive high levels of ketone bodies. phrine was in j ected into the mother before birth After this has continued f or some time, however, Q£ non . viable £etuseSj a p pre ciable amounts of compensating mechanisms come into force. radioactivity were rec overed from umbilical Increased insulin levels followmg elevated cord . and f eta l heart blood [53] . ZUSPAN, WHALEY, glucose concentrations support glucose assi-NELSON and AHLQUIST [74] concluded from the milation. In addition, increased lactate con-Wgh increase of glucose concentrations in fetal pentrations may flow into gluconeogenesis. blood following epinephrine infusion to the Resynthesis of neutral fats is enhanced, ketone mother^ that sufficie nt epinephrine had passed body concentrations decrease, and the acute acrQSS the placenta to -mducc ad ditional glucose alterations balance. mobilization in the fetus. MORGAN, SANDLER The changes in maternal acid-base parameters, and PANIGEL [41] were able to demonstrate a which indicate an acute metabolic acidosis rapid transfer of the catecholamines norepineduring infusion of ß-mimetic tocolytics concur phrine and isoproterenol from the maternal to the well with these findings. After Inhibition of fetal side in perfused human placentas in vitro, uterine contractions in the first stage of labor by infusion of O.lmg TV 399/min or 2.5 § Th 6.1 Placental enzymes 1165 a/min actual pH values from fetal scalp During the placental passage, however, the capillary blood were found to be within normal catecholamines to some extent undergo metaboliranges [31] . When maternal base excess and pH zation and inactivation. Placental tissues contain decreased during infusion of Dilatol, these rather high activities of the two main catecholparameters changed in the way in the capillary amine degrading enzymes: monoamine oxidase blood [70] . During infusion of 2 § Th 1165 a/ and catechol-O-methyl transferase [13, 41, 60] . min, in accordance with maternal changes, fetal The placental monoamine oxidase, like the enactual pH and base excess were significantly zymes in the liver, kidney and elsewhere can lowered, whereas Po 2 and Pco 2 remained un-oxidize a number of aromatic monoamines, but altered [33] . Maternal hyperglycemia during in-is inactive against diamines like histamine. Again fusion of Dilydrin is rapidly reflected in the fetus like the liver enzyme, the activity of the placental [51] . Fetal pH values are within the normal ränge enzyme is proportional to the oxygen tension of in the umbilical artery; however, there is a the medium in which it acts [60] . Macroscopic tendency for them to decrease; Pco 2 , Po 2 and regressive altered placental tissue metabolizes O 2 -saturation display no alterations [51] . Rises of less fetus from the damaging access of catecholamines into its circulation [41] . Also uterine tissue contains both the enzyme activities [13, 60] , Moreover, the fetus and newborn themselves appear to be equipped with the two key catecholamine degrading enzymes in their own right [17, 48] . Catechol-O-methyl transferase is found in human liver before birth, and its activity increases with age [1] . In livers of fetuses at the 3rd-4th month of gestation, high activities of monoamine oxidase and catechol-Omethyl transferase are present. Brain and heart tissues contain catechol-O-methyl transferase but less monoamine oxidase activities [13] , The authors [l, 13] suggest that in an early state in fetal tissues catecholamines are mainly degraded by catechol-O-methyl transferase, monoamine oxidase gaining importance later. In a case of phaeochromocytoma in pregnancy, distinctly lower catecholamine concentrations were observed in umbilical blood than in maternal blood, presumably due to vigorous inactivation [59] . Increased induction of the catecholamine metabolizing enzymes by the continous high Substrate supply may be discussed in such cases.
Changes in fetal metabolism
According to the results described above, it has to be taken into consideration that during ß-mimetic tocolytic therapy glycogenolysis and lipolysis occur in the mother äs well äs in the fetus. If after 2-3 hours of jS-mimetic tocolytic infusion the therapy fails, a metabolic acidosis, resulting from increased concentrations of acid metabolites: lactate, acetoacetate, ß-hydroxybutyrate in the fetus has to be anticipated.
The glycogen reserves may be depleted, and fetal hypoglycemia is subsequently endangering the newborn. After a longer-lasting therapy, however, the initial ß-stimulated metabolic changes have balanced out and are likely tobe of less importance.
A first report on 51 children, born after longtime tocolysis with Th 1165 a, who were thoroughly followed up biochemically and neurologically to the age of 18 months did not reveal any impairments [65] . Recent results indicate that Estriol-and HPLconcentrations may have a tendency to increase of less than the normal rate during long-time /?-mimetic therapy, though growth of the fetal biparietal diameter is regulär at the same time [27] . 4 cases of sudden intrauterine death during tocolytic therapy have been reported [4, 47, 62] . In 3 of these stillbirths regressive changes and fibrocalcific deposits were found in the placenta.
Recently ZLATNIK [73} emphasized that labor Inhibition is applicable only to a minority of patients with impending premature births, thus reducing over-optimistic expectations. In addition to regarding the well-outlined contraindications of tocolytic therapy, an assessment of the fetal condition has to be conducted.When faulty intrauterine environments exist because of poor maternal nutrition, reduced uterine bloöd-flow, chronic maternal disease, a pte-term delivery under careful monitoring would be more suitable than an useless prolongation of the pregnancy. The fetus is involved in two ways: 1. The maternal cardiovascular and metabolic alterations affect the fetus indirectly, 2. The tocolytic agent is transferred across the placenta and is triggering the same responses in the fetal organism itself. Maternal hypotension, induced by tocolysis can have detrimental consequences for the fetus, especially when a supine hypotensive syndrome is favoured and the utero-placental blood-flow collapses. A lateral position during infusion of /3-mimetic tocolytics is recommended. On the other hand, j9-stimulated peripheral vasodilatation, together with a wider pulse amplitude, which results from unchanged systolic blood pressure when the diastolic tension is lowered, and an increased maternal cardiac Output, consequently enhance placental perfusion, improving the oxygen supply to the fetus. In particular this is the case, when this effect is additional to the desired relaxation of the Uterus, or when a chronic placental insufficiency exists. Higher birth-weight after long-time administration of tocolytic jf?-mimetics may be explained by better uteroplacental circulation, and or by increased blood glucose levels. Immediately after starting a tocolytic infusion of /8-mimetics, lipolysis and glycogenolysis are triggered. The glycogen depots are mobilized. High lactate levels indicate preferred hydrolysis of muscle glycogen. Acute lipolytic mobilizing of neutral fat depots causes increase of free fatty acids, the high concentrations of which evidently block the metabolizing of acetyl-co-A, thus leading to excessive high levels of ketone-bodies. Subsequently, however, compensating regulations are commencing: Increased insulin levels folloxving elevated glucose concentrations support glucose assimilation; increased lactate concentrations may flow into gluconeogenesis. Resynthesis of neutral fats is enhanced, ketoacid concentrations decrease. In good coincidence with these findings are the changes in maternal acid-baseparameters, which indicate an acute metabolic acidosis during infusion of ß-mimetic tocolytics. There can be no doubt, that small molecules, like glucose, lactate, pyruvate, acetoacetate and j3-hydroxybutyrate readily pass across the placental membranes into the fetal organism. Maternal high concentrations of acid metabolites are most likely to produce a fetal metabolic acidosis. Catecholamines and catecholamine derivatives themselves do cross the placenta in humans and additionally induce the typical /?-stihmlated responses in the fetal organism itself. In placental and fetal tissues ß-mimetic catecholamines are likely to be metabolized. The two catecholamine degrading enzyme activities monoamine oxidase and catechol-O-methyl transferase have been identified in placental and fetal tissues, so that to some extent inactivation and protection may be possible. In the practical use it has to be realized, that during /ff-mimetic tocolytic therapy glycogenolysis and lipolysis occur in the mother äs well äs in the fetus. When after 2-3 hours of ß-mimetic tocolytic infusion the therapy fails, a metabolic acidosis, resulting from ingreased concentrations of acid metabolites: lactate, acetoacetate, /?-hydroxybutyrate has to be anticipated in the newborn. The glycogen depots may be depleted and hypoglycemia is endangering the newborn. After long-time therapy, however, the initial ß-stimulated metabolic changes have balanced and are likely to be of less importance. Infänts followed up biochemically and neurologically for 18 months after tocolytic therapy did not display any signs of impairment. Before starting a tocolytic therapy, fetal condition should be evaluated carefully. In cases of severe reduction of placental function, a preterm delivery may be more favourable to the fetus than any Prolongation of the pathologic pregnancy.
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